Posaconazole
- PDF / 169,633 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 52 Downloads / 154 Views
1 S
Pseudohyperaldosteronism: case report A single-center, retrospective, observational case-control study of 69 patients, including the patients diagnosed with posaconazole-induced pseudohyperaldosteronism between 2017 and 2018, and contemporaneous controls receiving posaconazole therapy, described a patient [age and sex not stated], who developed pseudohyperaldosteronism during treatment with posaconazole. The patient, who had started receiving antifungal therapy with oral posaconazole tablets [dosage not stated] at least 7 days previosuly, exhibited an increase in systolic blood pressure (SBP) by >10mm Hg (secondary hypertension) and a decrease in serum potassium by
Data Loading...
